• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Astrotech Corporation (DE) filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    7/22/26 8:41:03 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $ASTC alert in real time by email
    astc20260721_8k.htm
    false 0001001907 0001001907 2026-07-16 2026-07-16


     
    UNITED STATES
     
    SECURITIES AND EXCHANGE COMMISSION
     
    WASHINGTON, DC 20549
     
     

     
    FORM 8-K
     

     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934
     
    Date of report (Date of earliest event reported): July 16, 2026
     
     
    logo.jpg
     
    Astrotech Corporation
     
    (Exact Name of Registrant as Specified in Charter)
     
     
    Delaware
     
    001-34426
     
    91-1273737
    (State or Other Jurisdiction
    of Incorporation)
     
    (Commission
    File Number)
     
    (I.R.S. Employer
    Identification No.)
     
     
    1817 W. Braker Lane, Suite 400, Austin, Texas
     
    78758
    (Address of Principal Executive Offices)
     
    (Zip Code)
     
    (512) 485-9530
     
    Registrant’s Telephone Number, Including Area Code
     
    (Former Name or Former Address, if Changed Since Last Report)
     
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     
     
    ☐
    Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
     
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
     
    ☐
    Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
     
    ☐
    Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     

     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each class
     
    Trading
    Symbol(s)
     
    Name of each exchange on which registered
    Common Stock, $0.001 par value per share
     
    ASTC
     
    NASDAQ Stock Market, LLC
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
     

     
    Item 5.02         Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
     
    On July 16, 2026, the Board of Directors (the “Board”) of Astrotech Corporation (the “Company”) increased the size of the Board from six directors to seven directors and appointed Matthew Kreps to the Board to serve as a director until the Company’s 2026 annual meeting of stockholders and until his successor is duly elected and qualified or until his earlier death, resignation, or removal. As of the date of this filing, Mr. Kreps has not been appointed to any committees of the Board.
     
    Matt Kreps, 49, is a financial and capital markets executive with more than 25 years of experience leading investor relations and equity capital markets programs for publicly traded companies and companies trading on the over-the-counter markets. Since November 2024, Mr. Kreps has served as Senior Vice President of Capital Markets and Investor Relations of HydroGraph Clean Power Inc. (CSE: HG; OTCQB: HGRAF). Additionally, since 2016, Mr. Kreps has served as Managing Director at Darrow Associates Investor Relations. Before joining Darrow Associates in 2016, Mr. Kreps held senior investor relations roles at Shelton Group from 2009 to 2016, Magnolia Investor Relations from 2007 to 2009, and Halliburton Investor Relations from 2001 to 2007. Mr. Kreps received his Executive MBA in Global Leadership from The University of Texas at Dallas and a Bachelor of Science in Mass Communications from Kansas State University.
     
    The Company believes Mr. Kreps is qualified to serve as a director of the Company because of his extensive experience in capital markets, investor relations, corporate governance and shareholder engagement.
     
    Mr. Kreps will receive the Company’s standard compensation for non-employee directors, which is described in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on October 28, 2025. In connection with his appointment, the Board granted to Mr. Kreps of 2,150 shares of restricted stock under the Company’s 2021 Omnibus Equity Incentive Plan, vesting in equal installments on the first three anniversaries of the date of grant, subject to the terms and conditions of the applicable restricted stock award agreement. There are no arrangements or understandings between Mr. Kreps and any other person pursuant to which Mr. Kreps was named a director of the Company. Mr. Kreps does not have any direct or indirect material interest in any transaction or proposed transaction required to be reported under Item 404(a) of Regulation S-K.
     
    Item 7.01.         Regulation FD Disclosure.
     
    On July 22, 2026, the Company issued a press release announcing the appointment of Mr. Kreps to the Board. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K (the “Current Report”).
     
    The information set forth under Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit 99.1, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing, except as expressly set forth by specific reference in such a filing.
     
    Item 9.01.         Financial Statements and Exhibits.
     
    (d) Exhibits.
     
    Exhibit
    No.
    Description
    99.1
    Press Release, dated July 22, 2026, issued by Astrotech Corporation.
    104
    Cover Page Interactive Data File (embedded within the Inline XBRL document).
     

     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
    Date: July 22, 2026
    Astrotech Corporation
     
     
     
     
     
     
    By:
    /s/ Thomas B. Pickens III
     
     
     
    Name: Thomas B. Pickens III
     
     
     
    Chief Executive Officer, Chief Technology Officer and Chairman of the Board
    (Principal Executive Officer and Principal Financial Officer)
     
     
     
    Get the next $ASTC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASTC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ASTC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ASTROTECH APPOINTS MATT KREPS TO BOARD OF DIRECTORS

    AUSTIN, Texas, July 22, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) announced today that it has increased the size of its Board of Directors from five to six directors and has appointed Matt Kreps as a director of the Company. Mr. Kreps brings to Astrotech’s Board extensive financial and capital markets experience leading investor relations and equity capital markets programs for publicly traded companies and companies across multiple exchanges and jurisdictions. Mr. Kreps stated, "I am honored to join the Board of Astrotech. I look forward to working closely with my fellow Board members to support the Company’s strategic objectives as it continues to advance its lunar r

    7/22/26 8:37:57 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Corporation Submits Proposal to NASA's Commercial Lunar Payload Services 2 Program

    AUSTIN, Texas, June 30, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company"), a science and technology company with prior deep operational spaceflight heritage, today announced that it has submitted a proposal to NASA under the agency's Commercial Lunar Payload Services 2 ("CLPS2") program. Astrotech's Phase 1 proposal seeks approximately $20 million in non-dilutive NASA funding to support the initial stage of a proposed lunar technology demonstration program. The Company estimates that it would seek additional NASA funding from the CLPS2 program for this initiative if fully implemented and authorized by NASA. CLPS2 is structured as a multipl

    6/30/26 8:30:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Board Approves Potential Sale Process of 1st Detect and TRACER 1000, the Only Field-Deployed Mass Spectrometry ETD, as the Company Focuses on Its Initiative in Space

    AUSTIN, Texas, June 16, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") today announced that its Board of Directors has approved a potential sale process of its 1st Detect Corporation subsidiary ("1st Detect"), developer of the TRACER 1000 mass spectrometry–based explosives and narcotics trace detection ("ETD") platform. The TRACER 1000 is the only mass spectrometry ETD certified and field-deployed in aviation security operations, at a moment when U.S. and European authorities have signaled a shift away from the legacy ion mobility spectrometry ("IMS") technology that has dominated the market for three decades. The Company is evaluating a potenti

    6/16/26 8:30:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Halinski John William was granted 1,055 shares, increasing direct ownership by 9% to 12,211 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    7/21/26 4:42:22 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Winn Charles Arch was granted 1,055 shares, increasing direct ownership by 11% to 10,950 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    7/21/26 4:40:11 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Mcfarland Robert N was granted 1,055 shares, increasing direct ownership by 10% to 11,205 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    7/21/26 4:38:48 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Becker James Frank bought $19,675 worth of shares (2,034 units at $9.67), increasing direct ownership by 14% to 16,121 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/30/24 9:16:58 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Hinojosa Jaime bought $8,541 worth of shares (900 units at $9.49), increasing direct ownership by 13% to 7,881 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/28/24 9:46:54 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Wilkinson Thomas Wiley bought $10,536 worth of shares (1,109 units at $9.50), increasing direct ownership by 6% to 20,862 units (SEC Form 4)

    4 - ASTROTECH Corp (0001001907) (Issuer)

    5/21/24 12:54:36 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Leadership Updates

    Live Leadership Updates

    View All

    ASTROTECH APPOINTS MATT KREPS TO BOARD OF DIRECTORS

    AUSTIN, Texas, July 22, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) announced today that it has increased the size of its Board of Directors from five to six directors and has appointed Matt Kreps as a director of the Company. Mr. Kreps brings to Astrotech’s Board extensive financial and capital markets experience leading investor relations and equity capital markets programs for publicly traded companies and companies across multiple exchanges and jurisdictions. Mr. Kreps stated, "I am honored to join the Board of Astrotech. I look forward to working closely with my fellow Board members to support the Company’s strategic objectives as it continues to advance its lunar r

    7/22/26 8:37:57 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Reports Second Quarter of Fiscal Year 2026 Financial Results

    AUSTIN, Texas, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") reported its financial results for the second quarter of fiscal year 2026, which ended December 31, 2025. Financial Highlights & Recent Developments Research and development expense was $1,832 thousand, a decline of 25% from the second quarter of fiscal year 2025 as the Company transitions from development stage to saleable products for its EN-SCAN Handheld GC and 1st Detect Tracer 1000 product lines.Through December 31, 2025, the Company has deployed the TRACER 1000 trace detection system in approximately 35 locations in 16 countries across the United States, Europe and As

    2/13/26 8:15:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Subsidiary 1st Detect Appoints Industry Veteran David Spada as Director of Global Sales to Expand Global Reach of TRACER 1000™

    AUSTIN, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") today announced that its subsidiary, 1st Detect Corporation ("1st Detect"), has appointed industry veteran, David Spada, as Director of Global Sales. This strategic hire strengthens 1st Detect's commercial leadership as the company scales deployment of its TRACER 1000™ mass spectrometry-based explosives and narcotics trace detector across international security markets. Mr. Spada brings over a decade of specialized trace detection experience to the 1st Detect team. Throughout his career at Implant Sciences, Morpho Detection, and Rapiscan Systems, Mr. Spada has held position

    1/21/26 4:15:00 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Astrotech Corporation (DE)

    SC 13D - ASTROTECH Corp (0001001907) (Subject)

    6/26/23 4:00:53 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

    SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

    2/8/23 5:29:16 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Astrotech Corporation (DE) (Amendment)

    SC 13G/A - ASTROTECH Corp (0001001907) (Subject)

    2/8/23 4:02:50 PM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    SEC Filings

    View All

    Astrotech Corporation (DE) filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ASTROTECH Corp (0001001907) (Filer)

    7/22/26 8:41:03 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form EFFECT filed by Astrotech Corporation (DE)

    EFFECT - ASTROTECH Corp (0001001907) (Filer)

    7/8/26 12:15:17 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form S-3 filed by Astrotech Corporation (DE)

    S-3 - ASTROTECH Corp (0001001907) (Filer)

    6/30/26 6:02:46 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASTC
    Financials

    Live finance-specific insights

    View All

    Astrotech Announces Listing to the GSA as an Approved United States Government Vendor

    Astrotech Announces Listing to the GSA as an Approved United States Government Vendor AUSTIN, Texas, April 08, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation (1st Detect), announce that 1st Detect's TRACER 1000TM is now listed in the U.S. General Services Administration (GSA) IT Schedule 70 under Contract No. GS-35F-250GA with SRI Group LLC, Special Item Number 334290.   IT Schedule 70 is a long-term contract issued by the GSA to commercial technology vendors that allows sales to the U. S. federal government, one of the largest buyers of goods and services in the world. GSA's thoro

    4/8/24 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference

    AUSTIN, Texas, April 02, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation, announces that it will be showcasing its TRACER 1000 Narcotics Trace Detector ("NTD") and Explosives Trace Detector ("ETD") at the International Security Conference and Exposition, also known as ISC West, in Las Vegas, Nevada, from April 9-12, 2024, in booth number 2067. The TRACER 1000 is a high-performance laboratory instrument that is powered by the Astrotech Mass Spectrometer Technology™ ("AMS Technology"). Our mass spectrometer is capable of rapid detection of trace levels of narcotic or explosive compounds in

    4/2/24 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Astrotech Introduces the "Gold Standard" of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000

     AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation, announces that it is currently accepting orders for the Tracer 1000 Narcotics Trace Detector (NTD). The TRACER 1000 NTD is a high-performance laboratory instrument capable of rapid detection of trace levels of narcotic compounds in seconds. Currently, the Company's Tracer 1000 Explosive Trace Detector (ETD) is now found in multiple locations in 14 countries throughout the world. The NTD provides a ruggedized platform that can be applied across various markets including airports, border security, checkpoint, cargo,

    3/25/24 9:00:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials